DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01681 CONSUN PHARMA

Trading Add to Porfolio
Index Constituent : None
Major Shareholders AN Meng (27.08%)
Young Wai Po Peter (12.91%)
Li Zhenfu (5.03%)
FMR LLC (5.01%)
Sector Health Care & Biotechnology
Web Site http://www.chinaconsun.com Tel (86 20) 8226-4529
Email ir@chinaconsun.com Fax (86 20) 8226-1886
Related Equities N/A
Principal Activities Principally engaged in manufacturing and sales of pharmaceuticals.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
安郁寶 225,879,817(L)  25.81(L)  02/01/2019
BOS Trustee Limited as Trustee 196,674,000(L)  22.51(L)  06/04/2018
黎倩 151,720,261(L)  17.34(L)  02/01/2019
Lazard Asset Management LLC 43,978,000(L)  5.02(L)  26/09/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
唐寧 2,805,600(L)  0.32(L)  02/01/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top